Diane M. Simeone, MD
@MadameSurgeon
Surgeon, clinician and researcher at @nyulangone. Director of NYU's Pancreatic Cancer Center and passionate about increasing survival of #PancreaticCancer
ID:1008796555728613377
https://nyulangone.org/doctors/1215038138/diane-m-simeone 18-06-2018 19:40:16
556 Tweets
2,2K Followers
416 Following
Happening now at 11:00am ET Doctor Radio as I join Dr. Caren Behar in discussion on general pancreatic cancer segment in honor of November being Pancreatic Cancer Awareness Month.
Tune in tomorrow 11:00am ET Doctor Radio as I join Dr. Caren Behar in discussion on general pancreatic cancer segment in honor of November being Pancreatic Cancer Awareness Month.
On the cover of Clinical Cancer Research - KRAS wild type #PancreaticCancer with an oncogenic ROS1 fusion.
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer
From Hale Family Center For Pancreatic Cancer Research
aacrjournals.org/clincancerres/…
Accompanying commentary
aacrjournals.org/clincancerres/…
@AGITG2023 Australasian GI Clinical Trials Scientific Meeting! Building a worldwide network to improve global clinical trials for GI Cancers! Excited to give keynote on pancreatic cancer- a worldwide problem for us to solve together. #pancreaticcancer #GIClinicaltrials
Please read the exciting updates on the The PRECEDE Consortium Study
TrovaNOW #PancreaticCancer #earlydetectionpancreaticcancer Oncology Times
journals.lww.com/oncology-times…
The PRECEDE Consortium aims to improve #PancreaticCancer survival from 11% to 50% in the coming decade. “We're already starting to get some results,” said Diane Simeone, MD, Director of the Pancreatic Cancer Center at NYU Langone Health. ow.ly/ckz950Q70R3 Diane M. Simeone, MD
On Wednesday 15th November, there will be a #PancreaticCancer Awareness Month Members’ Debate in the Scottish Parliament.
If you live in Scotland, please make sure your MSPs is there to represent you by clicking this link: campaigns.pancreaticcancer.org.uk/page/138121/ac…
We all know that KRAS drives metabolic reprogramming in #PancreaticCancer but what are the metabolic perturbations facilitating the very earliest stages of multi step neoplasia (acinar to ductal metaplasia or ADM)?
New preprint from Lyssiotis Lab by Megan Radyk, PhD on some of these…